www.quantgene.com Open in urlscan Pro
34.234.52.18  Public Scan

Form analysis
0 forms found in the DOM

Text Content

For Patients
For Hospitals
For PhysiciansFor Employers
Science




WE END CANCER


INTELLIGENT GENOMICS FOR PATIENTS AND HOSPITALS

Our solutions use the power of genomics to translate findings into early cancer
signal detection.
Read the science



MEET INTELLIGENT GENOMICS

Quantgene started in 2015 at UC Berkeley.

8 years later, and $36m invested in R&D,  

We're launching Qx and Qi genomics platforms, available across the US.1

By combining genomics algorithms with patented high sensitivity diagnostics
technology, imaging, and medical data, we offer comprehensive medical
intelligence that helps identify early signals of cancer helping patients
achieve preventative and targeted clinical outcomes.
‍
1 Except New York.
Our clinical research partners




INTELLIGENT GENOMICS CAN END CANCER

Qx for Patients
A universal cancer screening solution.

This is achieved by combining high-sensitivity genomics with imaging & medical
data to identify early cancer signals using a standard blood sample. Early
detection enables preventative interventions and drastically improves survival
rates.1

1. An early diagnosis is made only after a healthcare provider reviews
confirmatory diagnostic tests and biopsies
Explore Qx

Qi for Hospitals
If you're a hospital, Qi can help you establish and manage state-of-the-art
genomics testing infrastructure in your premises, enabling you to offer genomics
to your patients, in-house.
‍
Talk to us to know more about bringing Qi to your healthcare facility.
Explore Qi



TRUSTED BY THE BEST IN THE INDUSTRY

"I believe Quantgene is a unique group of people with great respect for academic
research and extensive knowledge of clinical science. Quantgene has been a great
partner to me in my academic clinical research and very helpful in our attempt
to improve cancer risk determination in high-risk populations of women."
Dr. Setsuko Chambers
Chair of Ovarian Cancer Research
"We use Quantgene’s genomics technology in my clinical research for early cancer
detection, and I couldn’t think of a better partner. Using Genomics for early
detection is one of the most promising innovation pathways to reduce cancer
deaths in America."
Dr. Dan Raz
Director, Lung & Thoracic Program



WHAT MAKES BREAKTHROUGH TECHNOLOGY?

At Quantgene, there is no “not invented here “ syndrome. Our only goal is to end
cancer by any means necessary. For our research, that means we develop
proprietary technologies and when it makes sense; integrate third party
components. The result is industry-leading solutions free of vanity and special
interests that are optimized to end cancer.

Our breakthrough cfDNA liquid biopsy screening works by identifying early cancer
signals in the blood using genomic algorithms.
Read the science
AboutTwitterFacebookInstagram
Order Qx SupportNewsroomBlog
Login to Qx PortalTerms of UseRefund PolicyPrivacy Policy
contact@quantgene.com
‍
1920 NE Stucki Ave,
Ste 100,
Hillsboro, OR 97006

Qx is not cleared by the FDA. Downstream diagnostics might not be covered by
your insurance.
Copyright 2024 - Quantgene Inc